Pharmaceutical Technology on MSN
GSK’s Nucala secures NICE COPD endorsement
NICE now recommends Nucala for both severe asthma and COPD, expanding the drug’s clinical uptake across the UK’s public ...
Your patients with chronic obstructive pulmonary disease (COPD) may need help not just coping with their condition but also managing it in their workplace. The symptoms of COPD, a lung and airway ...
Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...
Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
US patients with chronic obstructive pulmonary disease (COPD) managed in primary care settings have high exacerbations, symptoms, and treatment burdens, according to an analysis of electronic health ...
Some patients with chronic obstructive pulmonary disease, or COPD, are breathing easier thanks to new technology in the form of a small valve inserted in the lung. Paula Dote had the Zephyr valves ...
DIGITAL COPD inhaler training reduced technique errors and improved assessment of inspiratory capacity in a new study. COPD ...
In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results